Literature DB >> 22451678

Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2.

Ying-Nai Wang1, Heng-Huan Lee, Hong-Jen Lee, Yi Du, Hirohito Yamaguchi, Mien-Chie Hung.   

Abstract

Nuclear localization of multiple receptor-tyrosine kinases (RTKs), such as EGF receptor (EGFR), ErbB-2, FGF receptor (FGFR), and many others, has been reported by several groups. We previously showed that cell surface EGFR is trafficked to the nucleus through a retrograde pathway from the Golgi to the endoplasmic reticulum (ER) and that EGFR is then translocated to the inner nuclear membrane (INM) through the INTERNET (integral trafficking from the ER to the nuclear envelope transport) pathway. However, the nuclear trafficking mechanisms of other membrane RTKs, apart from EGFR, remain unclear. The purpose of this study was to compare the nuclear transport of EGFR family proteins with that of FGFR-1. Interestingly, we found that digitonin permeabilization, which selectively releases soluble nuclear transporters from the cytoplasm and has been shown to inhibit nuclear transport of FGFR-1, had no effects on EGFR nuclear transport, raising the possibility that EGFR and FGFR-1 use different pathways to be translocated into the nucleus. Using the subnuclear fractionation assay, we further demonstrated that biotinylated cell surface ErbB-2, but not FGFR-1, is targeted to the INM, associating with Sec61β in the INM, similar to the nuclear trafficking of EGFR. Thus, ErbB-2, but not FGFR-1, shows a similar trafficking pathway to EGFR for translocation to the nucleus, indicating that at least two different pathways of nuclear transport exist for cell surface receptors. This finding provides a new direction for investigating the trafficking mechanisms of various nuclear RTKs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22451678      PMCID: PMC3351284          DOI: 10.1074/jbc.M111.314799

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Signalling shortcuts: cell-surface receptors in the nucleus?

Authors:  Alan Wells; Ulrich Marti
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

Review 2.  Structural and functional diversity in the FGF receptor multigene family.

Authors:  D E Johnson; L T Williams
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

3.  Nuclear trafficking of FGFR1: a role for the transmembrane domain.

Authors:  Jason M Myers; Gabriel G Martins; Jacek Ostrowski; Michal K Stachowiak
Journal:  J Cell Biochem       Date:  2003-04-15       Impact factor: 4.429

4.  Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.

Authors:  Shao-Chun Wang; Huang-Chun Lien; Weiya Xia; I-Fen Chen; Hui-Wen Lo; Zhiqin Wang; Mohamed Ali-Seyed; Dung-Fang Lee; Geoffrey Bartholomeusz; Fu Ou-Yang; Dipak K Giri; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2004-09       Impact factor: 31.743

5.  Induction of DNA synthesis in primary mouse hepatocytes is associated with nuclear pro-transforming growth factor alpha and erbb-1 and is independent of c-jun.

Authors:  Elisabeth Schausberger; Robert Eferl; Wolfram Parzefall; Monica Chabicovsky; Paul Breit; Erwin F Wagner; Rolf Schulte-Hermann; Bettina Grasl-Kraupp; Monica Chabikovsky
Journal:  Carcinogenesis       Date:  2003-05       Impact factor: 4.944

6.  A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma.

Authors:  Rosalyn M Adam; Theodora Danciu; Dawn L McLellan; Joseph G Borer; Jianqing Lin; David Zurakowski; Michael H Weinstein; Paul H Rajjayabun; J Kilian Mellon; Michael R Freeman
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

7.  Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration.

Authors:  S E Raper; S J Burwen; M E Barker; A L Jones
Journal:  Gastroenterology       Date:  1987-05       Impact factor: 22.682

8.  Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C.

Authors:  Hu Peng; Jason Myers; Xiaohong Fang; Ewa K Stachowiak; Pamela A Maher; Gabriel G Martins; Gabriela Popescu; Ronald Berezney; Michal K Stachowiak
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

9.  Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors.

Authors:  S A Adam; R S Marr; L Gerace
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

10.  Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation.

Authors:  J F Reilly; P A Maher
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

View more
  39 in total

1.  H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism.

Authors:  Mei-Kuang Chen; Yi Du; Linlin Sun; Jennifer L Hsu; Yu-Han Wang; Yuan Gao; Jiaxing Huang; Mien-Chie Hung
Journal:  J Biol Chem       Date:  2019-04-08       Impact factor: 5.157

Review 2.  Receptor tyrosine kinases in the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

3.  Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776.

Authors:  Yung-Luen Yu; Ruey-Hwang Chou; Chia-Han Wu; Ying-Nai Wang; Wei-Jung Chang; Yen-Ju Tseng; Wei-Chao Chang; Chien-Chen Lai; Hong-Jen Lee; Longfei Huo; Chung-Hsuan Chen; Mien-Chie Hung
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

4.  Translocation of Epidermal Growth Factor (EGF) to the nucleus has distinct kinetics between adipose tissue-derived mesenchymal stem cells and a mesenchymal cancer cell lineage.

Authors:  Camila Cristina Fraga Faraco; Jerusa Araújo Quintão Arantes Faria; Marianna Kunrath-Lima; Marcelo Coutinho de Miranda; Mariane Izabella Abreu de Melo; Andrea da Fonseca Ferreira; Michele Angela Rodrigues; Dawidson Assis Gomes
Journal:  J Struct Biol       Date:  2017-12-19       Impact factor: 2.867

5.  Selective Inhibition of STAT3 Phosphorylation Using a Nuclear-Targeted Kinase Inhibitor.

Authors:  Matthew D Bartolowits; Wells Brown; Remah Ali; Anthony M Pedley; Qingshou Chen; Kyle E Harvey; Michael K Wendt; Vincent Jo Davisson
Journal:  ACS Chem Biol       Date:  2017-08-18       Impact factor: 5.100

Review 6.  Non-canonical signaling mode of the epidermal growth factor receptor family.

Authors:  Heng-Huan Lee; Ying-Nai Wang; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

Review 7.  Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.

Authors:  Mei-Kuang Chen; Mien-Chie Hung
Journal:  FEBS J       Date:  2015-07-04       Impact factor: 5.542

8.  Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells.

Authors:  Ye Yuan; Si Chen; Tatjana Paunesku; Sophie Charlotte Gleber; William C Liu; Caroline B Doty; Rachel Mak; Junjing Deng; Qiaoling Jin; Barry Lai; Keith Brister; Claus Flachenecker; Chris Jacobsen; Stefan Vogt; Gayle E Woloschak
Journal:  ACS Nano       Date:  2013-11-27       Impact factor: 15.881

9.  Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.

Authors:  Mei-Kuang Chen; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

10.  mMAPS: a flow-proteometric technique to analyze protein-protein interactions in individual signaling complexes.

Authors:  Chao-Kai Chou; Heng-Huan Lee; Pei-Hsiang Tsou; Chun-Te Chen; Jung-Mao Hsu; Hirohito Yamaguchi; Ying-Nai Wang; Hong-Jen Lee; Jennifer L Hsu; Jin-Fong Lee; Jun Kameoka; Mien-Chie Hung
Journal:  Sci Signal       Date:  2014-03-04       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.